> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Status Report on NDA/BLA Postmarketing Requirements
- URL: https://www.fdaweb.com/fda-status-report-on-nda-bla-postmarketing-requirements/
- Published: 2016-10-31T12:00:00.000Z
- Updated: 2026-09-14T21:44:02.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5137216

*Federal Register* Notice: FDA has made available an annual report on the status of postmarketing requirements and postmarketing commitments involving approved drug and biological products. To view the report, click [here](http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Post-%20marketingPhaseIVCommitments/ucm064436.htm?ref=fdaweb.com). To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-10-31/pdf/2016-26247.pdf?ref=fdaweb.com).